Literature DB >> 1744306

Antibiotic levels in bronchial tree and in serum during selective digestive decontamination.

H Gastinne1, M Wolff, G Lachatre, R Boiteau, F P Savy.   

Abstract

Selective digestive decontamination has been found to prevent pulmonary infections in mechanically ventilated patients. The aims of this study were: 1) to determine whether detectable levels of antibiotics could be found in bronchial tree secretions of patients receiving SDD, and 2) to evaluate antibiotic serum levels. In 15 patients receiving mechanical ventilation and SDD for 10 days or more, tobramycin and amphotericin B levels were determined every 3 days in the following specimens: tracheal aspirates, distal bronchial secretions and blood samples. 82% of tracheal aspirates contained detectable (greater than 0.18 mg/l), tobramycin concentrations; the levels varied widely between patients and large day-to-day variations were observed. Every patient had at least 1 tracheal aspirate with tobramycin level higher than 0.5 mg/l during his course. 40% of distal specimens contained detectable tobramycin levels (10 patients). Serum determinations showed detectable concentration of tobramycin in 50% of the specimens (9 patients). Two patients with renal failure had serum tobramycin levels higher than 2 mg/l. In 13 tracheal aspirates cultures were positive and 15 species were isolated; 13 had a MIC higher than the corresponding tobramycin level in tracheal secretions. We conclude that substantial levels of antibiotics can be found frequently in respiratory tract specimens of patients receiving SDD. Therefore, the usual microbiological criteria used to assess respiratory tract infection may be unreliable in this setting and other criteria may be required. Follow-up of antibiotic serum levels is required, especially in patients with renal failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744306     DOI: 10.1007/bf01709880

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

1.  Risk factors for Amphotericin B-associated nephrotoxicity.

Authors:  M A Fisher; G H Talbot; G Maislin; B P McKeon; K P Tynan; B L Strom
Journal:  Am J Med       Date:  1989-11       Impact factor: 4.965

Review 2.  Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care.

Authors:  I M Ledingham; S R Alcock; A T Eastaway; J C McDonald; I C McKay; G Ramsay
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

3.  Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis.

Authors:  K Unertl; G Ruckdeschel; H K Selbmann; U Jensen; H Forst; F P Lenhart; K Peter
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

4.  Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections.

Authors:  N W Wimberley; J B Bass; B W Boyd; M B Kirkpatrick; R A Serio; H M Pollock
Journal:  Chest       Date:  1982-05       Impact factor: 9.410

5.  Prevention of colonization and infection in critically ill patients: a prospective randomized study.

Authors:  A J Kerver; J H Rommes; E A Mevissen-Verhage; P F Hulstaert; A Vos; J Verhoef; P Wittebol
Journal:  Crit Care Med       Date:  1988-11       Impact factor: 7.598

6.  Preventing lower airway colonization and infection in mechanically ventilated patients.

Authors:  R van Uffelen; J H Rommes; H K van Saene
Journal:  Crit Care Med       Date:  1987-02       Impact factor: 7.598

7.  Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques.

Authors:  J Y Fagon; J Chastre; Y Domart; J L Trouillet; J Pierre; C Darne; C Gibert
Journal:  Am Rev Respir Dis       Date:  1989-04

8.  Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.

Authors:  S H Powell; W L Thompson; M A Luthe; R C Stern; D A Grossniklaus; D D Bloxham; D L Groden; M R Jacobs; A O DiScenna; H A Cash; J D Klinger
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

Review 9.  Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation.

Authors:  H A Clasener; E J Vollaard; H K van Saene
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

10.  Pharmacokinetics of amphotericin B and flucytosine.

Authors:  A Polak
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

View more
  11 in total

1.  Selective decontamination of the digestive tract: to stimulate or stifle?

Authors:  Marc J M Bonten; Christian Brun-Buisson; Robert A Weinstein
Journal:  Intensive Care Med       Date:  2003-05       Impact factor: 17.440

2.  Rapid diagnosis of gram negative pneumonia by assay of endotoxin in bronchoalveolar lavage fluid.

Authors:  J Pugin; R Auckenthaler; O Delaspre; E van Gessel; P M Suter
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

Review 3.  Nosocomial pneumonia in the intensive care unit: mechanisms and significance.

Authors:  C A'Court; C S Garrard
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

4.  Effectiveness of antibiotic prophylaxis in critically ill patients. Distinction must be made between tracheal inflammation and pneumonia.

Authors:  P J Sanderson
Journal:  BMJ       Date:  1998-11-28

Review 5.  The relationship between gut-derived bacteria and the development of the multiple organ dysfunction syndrome.

Authors:  G A Nieuwenhuijzen; E A Deitch; R J Goris
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

6.  Pneumonia prevention: a step backwards.

Authors:  W G Johanson
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

7.  Oral Tobramycin Prophylaxis Prior to Colorectal Surgery Is Not Associated with Systemic Uptake.

Authors:  T Mulder; M F Q Kluytmans-van den Bergh; R M P H Crolla; A A M Ermens; J Romme; N E Van't Veer; J A J W Kluytmans
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 8.  Critical care pharmacotherapy. A review.

Authors:  M Tryba; P J Kulka
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

9.  Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study.

Authors:  J J Rouby; P Poète; E Martin de Lassale; M H Nicolas; L Bodin; V Jarlier; A M Korinek; P Viars
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

10.  Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study.

Authors:  Heleen M Oudemans-van Straaten; Henrik Endeman; Robert J Bosman; Milly E Attema-de Jonge; Marc L van Ogtrop; Durk F Zandstra; Eric J F Franssen
Journal:  Crit Care       Date:  2011-10-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.